keyword
https://read.qxmd.com/read/38645913/monoclonal-gammopathy-of-renal-significance-mgrs-case-series-from-a-tertiary-center-in-kerala
#1
Priya Padmanabhan, Jayameena P, Neena Mampilly, Shinto Francis, Ajmal Sherif, Sunil George, Thomas Mathew
Monoclonal gammopathy of renal significance (MGRS) has gained importance because identifying the monoclonal deposit and addressing it, rather than treating renal dysfunction as the primary pathology, has salvaged the patients from progressing into end-stage renal disease. Since it affects elderly population, there could be a propensity to misdiagnose them with cardiorenal syndrome. We present four patients of MGRS diagnosed from our center. They presented with proteinuria or unexplained renal dysfunction. Three of the patients were diagnosed to have amyloidosis, of which two had lambda-type and one had kappa amyloidosis...
2024: Indian Journal of Nephrology
https://read.qxmd.com/read/38635117/-non-exertional-variables-of-cardiopulmonary-exercise-testing-in-heart-failure-with-and-without-cardiac-amyloidosis
#2
REVIEW
Simon Wernhart, Lars Michel, Alexander Carpinteiro, Peter Luedike, Tienush Rassaf
PURPOSE OF REVIEW: Cardiac amyloidosis (CA) constitutes an important etiology of heart failure with preserved ejection fraction (HFpEF) or heart failure with mildly reduced ejection fraction (HFmrEF). Since patients with CA show early exhaustion, we aimed to investigate whether non-exertional variables of cardiopulmonary exercise testing (CPET) provide additional information in comparison to traditional peak oxygen consumption (VO2peak ). RECENT FINDINGS: We retrospectively investigated CPET variables of patients with HFpEF and HFmrEF with (n = 21) and without (n = 21, HF) CA at comparable age and ejection fraction...
April 18, 2024: Current Heart Failure Reports
https://read.qxmd.com/read/38623100/an-interesting-case-of-macular-amyloidosis-with-no-significant-etiology
#3
Avni Gakkhar, Ashok M Mehendale, Shivansh Mehendale
Macular amyloidosis is primary localized cutaneous amyloidosis (PLCA). It is described by the extracellular accumulation of heterogenic amyloid proteins in the skin that does not affect the systemic immune system, causing hyperpigmented patches. It is a prevalent skin disorder of young female adults, especially in India, since it affects the population with darker skin. History of frictional rub on the skin is typically present, such as using loofah or bathing scrubs or stones. The case presented below is of a 23-year-old female who presented with a hyperpigmented patch on the upper back of both sides and extensor surface of arms and did not have any history of usage of loofah on those areas, compelling us to research more on the other causative factors (genetic predisposition, infectious agents, and UV radiation are probable causative factors) for macular amyloidosis...
March 2024: Curēus
https://read.qxmd.com/read/38592132/arrhythmias-and-device-therapies-in-cardiac-amyloidosis
#4
REVIEW
Syed Bukhari, Syed Zamrak Khan, Mohamed Ghoweba, Bilal Khan, Zubair Bashir
Cardiac amyloidosis is caused by amyloid fibrils that deposit in the myocardial interstitium, causing restrictive cardiomyopathy and eventually death. The electromechanical, inflammatory, and autonomic changes due to amyloid deposition result in arrhythmias. Atrial fibrillation is by far the most common arrhythmia. The rate control strategy is generally poorly tolerated due to restrictive filling physiology and heart rate dependance, favoring adoption of the rhythm control strategy. Anticoagulation for stroke prophylaxis is warranted, irrespective of CHA2 DS2 -VASc score in patients with a favorable bleeding profile; data on left appendage closure devices are still insufficient...
February 25, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38584103/-analysis-of-clinical-manifestations-and-prognosis-of-primary-systemic-light-chain-amyloidosis-with-liver-involvement
#5
JOURNAL ARTICLE
T T Qiao, Y Liu, N Peng, L Z Gong, X L Dou, L Wen, J Lu
Objective: To summarize the clinical manifestations and prognostic factors of patients with hepatic amyloidosis in a single center. Methods: The clinical data of 28 primary systemic light chain amyloidosis cases with liver involvement in our center from October 2012 to January 2023 were retrospectively analyzed. The main clinical manifestations and prognostic factors were studied. Statistical analysis were performed using the χ(2) test, Fisher's exact test, Wilcoxon rank test, or Kaplan-Meier survival curve log-rank test according to the different data...
March 20, 2024: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/38583167/contemporary-american-and-european%C3%A2-guidelines-for-heart-failure-management-jacc-heart%C3%A2-failure-guideline-comparison
#6
REVIEW
John W Ostrominski, Ersilia M DeFilippis, Kannu Bansal, Ralph J Riello, Biykem Bozkurt, Paul A Heidenreich, Muthiah Vaduganathan
This review serves to compare contemporary clinical practice recommendations for the management of heart failure (HF), as codified in the 2021 European Society of Cardiology (ESC) guideline, the 2022 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Failure Society of America (HFSA) guideline, and the 2023 focused update of the 2021 ESC document. Overall, these guidelines aim to solidify significant advances throughout the HF continuum since the publication of previous full guideline iterations (2013 and 2016 for the ACC/AHA and ESC, respectively)...
March 13, 2024: JACC. Heart Failure
https://read.qxmd.com/read/38556822/-clinicopathological-features-of-sjogren-s-syndrome-complicated-with-liver-injury
#7
JOURNAL ARTICLE
X Y Han, L Zhang, K Yang, J M Chen, X G Zhou, X M Chen, Z Y Ma, L M Qi, P Wang, L Sun
Objective: To study the clinicopathological features of Sjogren's syndrome (SS) with liver injury and to improve the understanding of this disease. Methods: Forty-nine patients with SS complicated with liver injury were collected from Beijing Ditan Hospital, Capital Medical University from October 2008 to January 2022. All patients underwent ultrasound-guided liver biopsy, and all specimens were stained with HE. The histopathologic characteristics were observed and the pathologic indexes were graded. Immunohistochemical stains for CK7, CK19, CD38, MUM1 and CD10 were performed by EnVision method; and special histochemical stains for reticulin, Masson's trichrome, Rhodanine, Prussian blue, periodic acid Schiff (PAS) and D-PAS stains were conducted ...
April 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38550837/primary-systemic-amyloidosis-with-multisystem-involvement-a-case-report
#8
JOURNAL ARTICLE
M Sreevidya Suresh, Patnala Guruprasad, Jahnavi Sambangi, Sudhir Babu S Karri
No abstract text is available yet for this article.
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38548524/patisiran-an-rnai-therapeutic-for-hereditary-transthyretin-mediated-amyloidosis-sub-analysis-in-taiwanese-patients-from-the-apollo-study
#9
JOURNAL ARTICLE
Kon-Ping Lin, Chih-Chao Yang, Yi-Chung Lee, Ming-Jen Lee, John Vest, Marianne T Sweetser, Matthew T White, Prajakta Badri, Sung-Tsang Hsieh, Chi-Chao Chao
BACKGROUND AND OBJECTIVES: To examine the efficacy and safety of patisiran, an RNA interference therapeutic, in patients from Taiwan with hereditary transthyretin-mediated (hATTR) amyloidosis with polyneuropathy. METHODS: The APOLLO phase 3 trial included patients from Taiwan who received patisiran 0.3 mg/kg intravenously or placebo once every 3 weeks (q3w) for 18 months (18 M), followed by patisiran 0.3 mg/kg q3w in an ongoing global open-label extension (OLE) study...
March 27, 2024: Journal of the Formosan Medical Association
https://read.qxmd.com/read/38538076/benchmarking-digital-displays-monitors-for-histological-diagnoses-the-nephropathology-use-case
#10
JOURNAL ARTICLE
Giorgio Cazzaniga, Francesco Mascadri, Stefano Marletta, Alessandro Caputo, Gabriele Guidi, Giovanni Gambaro, Albino Eccher, Angelo Paolo Dei Tos, Fabio Pagni, Vincenzo L'Imperio
AIM: The digital transformation of the pathology laboratory is being continuously sustained by the introduction of innovative technologies promoting whole slide image (WSI)-based primary diagnosis. Here, we proposed a real-life benchmark of a pathology-dedicated medical monitor for the primary diagnosis of renal biopsies, evaluating the concordance between the 'traditional' microscope and commercial monitors using WSI from different scanners. METHODS: The College of American Pathologists WSI validation guidelines were used on 60 consecutive renal biopsies from three scanners (Aperio, 3DHISTECH and Hamamatsu) using pathology-dedicated medical grade (MG), professional grade (PG) and consumer-off-the-shelf (COTS) monitors, comparing results with the microscope diagnosis after a 2-week washout period...
March 27, 2024: Journal of Clinical Pathology
https://read.qxmd.com/read/38511180/trends-in-incidence-and-clinical-outcome-of-non-st-elevation-myocardial-infarction-in-patients-with-amyloidosis-in-the-united-states-2010-2020
#11
JOURNAL ARTICLE
John Gharbin, Adwoa Winful, Pamela Alebna, Niyati Grewal, Ahmed Brgdar, Suchelis Rhodd, Mohammed Taha, Urooj Fatima, Prafulla Mehrotra, Anekwe Onwuanyi
STUDY OBJECTIVE: To assess temporal changes in clinical profile and in-hospital outcome of patients with amyloidosis presenting with non-ST elevation myocardial infarction, NSTEMI. DESIGN/SETTING: We conducted a retrospective observational study using the National Inpatient Sample (NIS) database from January 1, 2010, to December 31, 2020. MAIN OUTCOMES: Primary outcome of interest was trend in adjusted in-hospital mortality in patients with amyloidosis presenting with NSTEMI from 2010 to 2020...
November 2023: American heart journal plus: cardiology research and practice
https://read.qxmd.com/read/38497794/prevalence-and-clinical-outcomes-of-isolated-or-combined-moderate-to-severe-mitral-and-tricuspid-regurgitation-in-patients-with-cardiac-amyloidosis
#12
JOURNAL ARTICLE
Daniela Tomasoni, Alberto Aimo, Aldostefano Porcari, Giovanni Battista Bonfioli, Vincenzo Castiglione, Riccardo Saro, Mattia Di Pasquale, Maria Franzini, Iacopo Fabiani, Carlo Mario Lombardi, Laura Lupi, Marta Mazzotta, Matilde Nardi, Matteo Pagnesi, Giorgia Panichella, Maddalena Rossi, Giuseppe Vergaro, Marco Merlo, Gianfranco Sinagra, Michele Emdin, Marco Metra, Marianna Adamo
AIMS: Evidence on the epidemiology and prognostic significance of mitral regurgitation (MR) and tricuspid regurgitation (TR) in patients with cardiac amyloidosis (CA) is scarce. METHODS AND RESULTS: Overall, 538 patients with either transthyretin (ATTR, n = 359) or immunoglobulin light-chain (AL, n = 179) CA were included at three Italian referral centres. Patients were stratified according to isolated or combined moderate/severe MR and TR. Overall, 240 patients (44...
March 18, 2024: European Heart Journal Cardiovascular Imaging
https://read.qxmd.com/read/38488658/light-chain-deposition-disease-presenting-with-gastrointestinal-disorder-as-primary-manifestation-report-of-two-cases-and-literature-review
#13
JOURNAL ARTICLE
Chenxiang Wei, Min Wang, Jiamin Li, Jiajun Su, Jing Huang, Sunwing Tong, Dongye Yang
Light chain deposition disease (LCDD) is an under-recognized condition characterized by deposition of abnormal monoclonal light chains in tissues, leading to organ dysfunction. LCDD involving the gastrointestinal tract is very uncommon, and its diagnosis is challenging. We herein report two cases of LCDD that manifested as inflammatory bowel disease-like symptoms and protein-losing gastroenteropathy. Both patients were women in their early 60s. Tissue biopsies from the gastrointestinal mucosa demonstrated extracellular deposits, which were negative by Congo red staining but positive for κ-light chain by immunohistochemistry...
March 2024: Journal of International Medical Research
https://read.qxmd.com/read/38458484/temporal-outcomes-of-patients-diagnosed-with-transthyretin-cardiac-amyloidosis
#14
JOURNAL ARTICLE
Nicholas Chan, Sergio Teruya, Alfonsina Mirabal, Ariel Y Weinsaft, Jeffeny De Los Santos, Samantha Guadalupe, Massiel Jimenez, Carlos Rodriguez, Stephen Helmke, Margaret Cuomo, Dia Smiley, Mathew S Maurer
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly recognized. Clinical outcomes have evolved over time amidst changes in the diagnostic pathway and advances in therapeutics. OBJECTIVE: To evaluate clinical outcomes over time of ATTR-CA patients with access to disease-modifying therapy. METHODS: This is a retrospective cohort study of 419 patients diagnosed with ATTR-CA during 2001-2021, comparing clinical characteristics across eras...
March 6, 2024: Journal of Cardiac Failure
https://read.qxmd.com/read/38453487/diagnostic-performance-of-blood-analytes-for-the-diagnosis-of-renal-disease-in-black-footed-ferrets-mustela-nigripes-at-the-phoenix-zoo-2001-2020
#15
JOURNAL ARTICLE
Alyssa G Palmer, Nicole I Stacy, Jorge A Hernandez, Alexandra Goe
Renal disease is an important cause of morbidity and mortality in managed black-footed ferrets (BFF; Mustela nigripes ).4,6,12 The objectives of this study were to establish reference intervals for blood analytes of clinically normal BFF (1-2 yr old), summarize the frequency of various renal histopathologic findings in a managed population of BFF, assess the diagnostic performance of blood analytes and urine specific gravity (USG) for the diagnosis of renal disease, and assess if comorbidities or age affects the performance of these analytes in diagnosing renal disease...
March 2024: Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians
https://read.qxmd.com/read/38441582/cardiac-amyloidosis-due-to-transthyretin-protein-a-review
#16
REVIEW
Frederick L Ruberg, Mathew S Maurer
IMPORTANCE: Systemic amyloidosis from transthyretin (ATTR) protein is the most common type of amyloidosis that causes cardiomyopathy. OBSERVATIONS: Transthyretin (TTR) protein transports thyroxine (thyroid hormone) and retinol (vitamin A) and is synthesized predominantly by the liver. When the TTR protein misfolds, it can form amyloid fibrils that deposit in the heart causing heart failure, heart conduction block, or arrhythmia such as atrial fibrillation. The biological processes by which amyloid fibrils form are incompletely understood but are associated with aging and, in some patients, affected by inherited variants in the TTR genetic sequence...
March 5, 2024: JAMA
https://read.qxmd.com/read/38427769/a-serious-warning-a-case-report-on-localized-amyloidosis-of-the-oral-cavity
#17
JOURNAL ARTICLE
Sharon John, Priyambadha Subba, Aravindhan Aramugam, Shalini Gupta, Richa Khanna
Amyloidosis is a relatively rare condition with an array of complex pathophysiology. Localized amyloidosis is a rare and benign condition that practically never results in any clinical repercussions in the head and neck area. Multiple soft nodules of the tongue, lip, and cheek are the most commonly described defining characteristics of localized oral amyloidosis. These nodules originate due to the proliferation of abnormally folded protein aggregates in the body's extracellular tissue compartments, which destroy organ structure and function...
February 19, 2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38408288/impact-of-premedication-de-escalation-on-incidence-of-infusion-related-reactions-with-daratumumab
#18
JOURNAL ARTICLE
Donna Vazirnia, Alejandro Del Rio Verduzco, Scott A Soefje, Kristyn A Sanders, Tyler B Sandahl
PURPOSE: Daratumumab is an anti-CD38 monoclonal antibody used to treat multiple myeloma and light chain amyloidosis. Because daratumumab may cause reactions after intravenous or subcutaneous (SC) administration, the manufacturer labeling recommends administration of premedications before every dose. Given incidence of infusion reactions appears to be rare after cycle 1, in April 2022, the Mayo Clinic implemented a practice change in which premedications were omitted from all daratumumab order sets after completion of cycle 1...
February 26, 2024: JCO oncology practice
https://read.qxmd.com/read/38399458/2023-fda-tides-peptides-and-oligonucleotides-harvest
#19
REVIEW
Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G de la Torre
A total of nine TIDES (pepTIDES and oligonucleoTIDES) were approved by the FDA during 2023. The four approved oligonucleotides are indicated for various types of disorders, including amyotrophic lateral sclerosis, geographic atrophy, primary hyperoxaluria type 1, and polyneuropathy of hereditary transthyretin-mediated amyloidosis. All oligonucleotides show chemically modified structures to enhance their stability and therapeutic effectiveness as antisense or aptamer oligomers. Some of them demonstrate various types of conjugation to driving ligands...
February 13, 2024: Pharmaceuticals
https://read.qxmd.com/read/38388204/rare-vertebral-pathological-fracture-in-primary-amyloidosis
#20
JOURNAL ARTICLE
Yusoff Norisyam, Kamarul Bahrin Zairul Anuar, Khin Maung Ohn, Mohamed Moharzudi
Spinal involvement in primary amyloidosis is an exceedingly rare condition, presenting with typical pathological fracture symptoms that are often indistinguishable from other pathologies such as bone metastasis, metabolic disorders and infections. Histopathological studies for tissue diagnosis are the cornerstone of a definitive diagnosis, leading to successful treatment. Early diagnosis and intervention play a pivotal role in the care of patients with amyloidosis. Here, we present a unique case of a pathological fracture in the L4 vertebra following minor trauma...
February 22, 2024: BMJ Case Reports
keyword
keyword
72204
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.